Maureen G. Maguire, PhD
Carolyn F. Jones Professor of Ophthalmology
Associate Scholar, Center for Clinical Epidemiology and Biostatistics, University of Pennsylvania, School of Medicine
Senior Scholar, Leonard Davis Institute for Health Economics, University of Pennsylvania, School of Medicine
Vice Chair for Clinical Research, Department of Ophthalmology, University of Pennsylvania, School of Medicine
Associate, Center for Public Health Initiatives, University of Pennsylvania
Department: Ophthalmology
Contact information
3535 Market Street, Suite 700
Philadelphia, PA 19104-3309
Philadelphia, PA 19104-3309
Office: 215-615-1501
Fax: 215-615-1531
Fax: 215-615-1531
Email:
maguirem@mail.med.upenn.edu
maguirem@mail.med.upenn.edu
Graduate Group Affiliations
Publications
Education:
B.A. (Mathematics)
Rider College Summa cum laude, Honors in Mathematics, 1975.
Sc.M. (Biostatistics)
The Johns Hopkins University School of Hygiene and Public Health , 1977.
Ph.D. (Biostatistics)
The Johns Hopkins University School of Hygiene and Public Health , 1983.
Permanent linkB.A. (Mathematics)
Rider College Summa cum laude, Honors in Mathematics, 1975.
Sc.M. (Biostatistics)
The Johns Hopkins University School of Hygiene and Public Health , 1977.
Ph.D. (Biostatistics)
The Johns Hopkins University School of Hygiene and Public Health , 1983.
Description of Research Expertise
Dr. Maguire is Director of the Center for Preventive Ophthalmology and Biostatistics with the Department of Ophthalmology. Current research projects include:1) directing the Coordinating Center for the NIH-funded Comparison of Age-related Macular Degeneration Treatments Trials, a multicenter, randomized clinical trial involving 1200 patients with choroidal neovascularization
2) screening for and treatment of eye conditions affecting preschool children
3) methodology in clinical research for ocular conditions including efficient study design and analysis of correlated data.
Dr. Maguire consults on many projects in vision science, both within and outside of the University.
Selected Publications
Walter SD, Ishikawa H, Galetta KM, Sakai RE, Feller DJ, Henderson SB, Wilson JA, Maguire MG, Galetta SL, Frohman E, Calabresi PA, Schuman JS, Balcer LJ: Ganglion cell loss in relation to visual disability in multiple sclerosis. Ophthalmology 2012 (in press).Maguire MG: Letter to the Editor. Drusen volume as a surrogate end point Ophthalmology 2012 (in press).
Galetta KM, Barrett J, Allen M, Madda F, Delicata D, Tennant AT, Branas CC, Maguire MG, Messner LV, Devick S, Galetta AL, Balcer LJ : The King-Devick test as a determinant of head trauma and concussion in boxers and MMA fighters. Neurology 76: 1456-62, 2011 Notes: Epub 2011 Feb.
Martin DF, Maguire MG, Fine SL: Ranibizumab and bevacizumab for AMD. Authors reply. N Engl J Med 365: 2237, 2011.
Ying G-S, Maguire M, Quinn G, Kulp M, Cyert L: ROC analysis of the accuracy of noncycloplegic retinoscopy, Retinomax autorefractor and SureSight vision screener for preschool vision screening Invest Ophthalmol Vis Sci 28 (52): 9658–9664, 2011 Notes: Epub 2011 Nov 28.
Zheng Y, Hunter AA 3rd, Wu J, Wang H, Gao J, Maguire MG, Gee JC: Landmark matching based automatic retinal image registration with linear programming and self-similarities. Inf Process Med Imaging 22: 674-85, 2011.
Ying G-S, Maguire MG, the Complications of Age-related Macular Degeneration Prevention Trial Research Group: Development of a risk score for geographic atrophy in the Complications of Age-Related Macular Degeneration Prevention Trial (CAPT). Ophthalmology 118: 332–338. 2011 Notes: Epub 2010 Aug 27.
Vision In Preschoolers (VIP) Study Group: Comparison of the Retinomax and Palm-AR auto-refractors: A pilot study. Optom Vis Sci 88: 830-6, 2011 Notes: Epub 2011 Apr 21.
Pineles SL, Birch EE, Talman LS, Sackel DJ, Frohman EM, Calabresi PA, Galetta SL, Maguire MG, Balcer LJ: One eye or two: A comparison of binocular and monocular low-contrast acuity testing in multiple sclerosis. Am J Ophthalmol 152: 133-40, 2011 Notes: Epub 2011 May 11.
The CATT Research Group: Ranibizumab and bevacizumab for neovascular age-related macular degeneration. N Engl J Med 364: 1897-1908, 2011 Notes: (Writing team member; Director of the Coordinating Center) Epub 2011 Apr 28.
